“A survey from Graphite clearly shows the pharma industry’s challenges as it tries to transition to a digital strategy. “Teams are struggling to measure the impact of digital solutions, limiting the scope for continuous improvement. Problems such as the misalignment of metrics with strategic KPIs, internal data silos, and the late setting of metrics are widespread. The issue of data security and privacy also presents one of the most significant sector-wide barriers to digital innovation.” “A survey from Graphite clearly shows the pharma industry’s challenges as it tries to transition to a digital strategy. “Teams are struggling to measure the impact of digital solutions, limiting the scope for continuous improvement. Problems such as the misalignment of metrics with strategic KPIs, internal data silos, and the late setting of metrics are widespread. The issue of data security and privacy also presents one of the most significant sector-wide barriers to digital innovation.”

SUMMARY: Quantitative and qualitative data was gained through surveys with EPG Health’s multi-stakeholder databases (HCP, pharma, and service providers) and interviews conducted with pharma execs by Impatient Health. The objective was to identify new and preferred pathways for the creation and delivery of medical information.